Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein A (HSPA), widely known as the Heat shock protein 70 (Hsp70) family, comprises a group of highly conserved molecular chaperones that are central to maintaining cellular proteostasis [1, 16]. These proteins function as ATP-dependent enzymes that facilitate the folding of nascent polypeptides, the refolding of denatured proteins, and the stabilization of proteins against aggregation under stress [1, 13]. The family includes both constitutively expressed members like HSPA8 (Hsc70), which perform essential housekeeping duties, and stress-inducible members like HSPA1A, which are upregulated in response to heat, hypoxia, and proteotoxic stress [11, 16]. In cancer, HSPA proteins are frequently overexpressed to support the stability of mutated oncoproteins and to evade apoptosis, making them attractive targets for small molecule inhibitors like VER-155008 and JG-98 [6, 11, 12]. Conversely, in neurodegenerative diseases such as Alzheimer's and Parkinson's, HSPA function is often impaired or insufficient to prevent the accumulation of toxic protein aggregates, suggesting a role for HSPA activators in therapy [5, 14]. Despite their therapeutic potential, targeting HSPA remains difficult due to the high structural homology between family members, which can lead to off-target effects and the induction of a compensatory heat shock response [6, 11].
HSPA modulators primarily function by inhibiting the ATPase activity of the N-terminal nucleotide-binding domain (NBD), disrupting the substrate-binding domain (SBD) interactions, or allosterically modulating the chaperone cycle. These actions prevent the proper folding of client proteins, leading to their aggregation or proteasomal degradation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein A (HSPA).